Skip to main content
. 2015 Oct 11;2015:696439. doi: 10.1155/2015/696439

Table 2.

Dose, fractionation schedules, and treatment groups.

Treatment intent Prescription dose Number of fractions Number of patients (%)
No ADT ADT Total
Definitive VMAT
 Intermediate risk 74 Gy 37 5 4 9
 High risk 78 Gy 39 1 15 16
 Total 6 (5%) 19 (17%) 25 (22%)
VMAT following HDR brachytherapy 50.4 Gy 28 9 (8%) 16 (14%) 25 (22%)
Salvage VMAT 66 Gy 33 38 (34%) 11 (10%) 49 (44%)
Adjuvant VMAT 66 Gy 33 9 (8%) 5 (4%) 14 (12%)
Total 62 (55%) 51 (45%) 113 (100%)